Nazila Assasi

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. doi request reprint Economic evaluations conducted for assessment of genetic testing technologies: a systematic review
    Nazila Assasi
    Programs for Assessment of Technology in Health PATH Research Institute, McMaster University, Hamilton, Canada
    Genet Test Mol Biomarkers 16:1322-35. 2012
  2. doi request reprint Patient outcomes after anti TNF-alpha drugs for Crohn's disease
    Nazila Assasi
    Programs for Assessment of Technology in Health Research Institute, St Joseph s Healthcare, Hamilton, 25 Main Street West, Suite 2000 ON, Canada
    Expert Rev Pharmacoecon Outcomes Res 10:163-75. 2010
  3. ncbi request reprint Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura
    Gord Blackhouse
    Programs for Assessment of Technology in Health PATH Research Institute, McMaster University, Hamilton, Ontario, Canada
    J Popul Ther Clin Pharmacol 19:e166-78. 2012
  4. doi request reprint Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease
    Gord Blackhouse
    Programs for Assessment of Technology in Health Research Institute, McMaster University, Hamilton, ON, Canada
    J Crohns Colitis 6:77-85. 2012
  5. doi request reprint Comparative effectiveness of catheter ablation strategies for rhythm control in patients with atrial fibrillation: a meta-analysis
    Nazila Assasi
    Programs for Assessment of Technology in Health Research Institute, McMaster University, Hamilton, ON, Canada L8P 1H1
    J Interv Card Electrophysiol 35:259-75. 2012
  6. pmc Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada
    Gord Blackhouse
    PATH Research Institute, McMaster University, Hamilton, Ontario, Canada
    Cost Eff Resour Alloc 8:14. 2010
  7. doi request reprint Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura
    Feng Xie
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    Clin Ther 31:1082-91; discussion 1066-8. 2009
  8. doi request reprint Triple therapy for the management of COPD: a review
    Kathryn Gaebel
    Programs for Assessment of Technology in Health PATH Research Institute, McMaster University, Hamilton, Ontario L8P 1H1
    COPD 8:206-43. 2011
  9. pmc Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
    Feng Xie
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    Cost Eff Resour Alloc 7:20. 2009
  10. doi request reprint Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic review
    Nazila Assasi
    Programs for Assessment of Technology in Health PATH Research Institute, McMaster University, Hamilton, ON, Canada
    Expert Rev Pharmacoecon Outcomes Res 14:203-20. 2014

Detail Information

Publications10

  1. doi request reprint Economic evaluations conducted for assessment of genetic testing technologies: a systematic review
    Nazila Assasi
    Programs for Assessment of Technology in Health PATH Research Institute, McMaster University, Hamilton, Canada
    Genet Test Mol Biomarkers 16:1322-35. 2012
    ..To systematically review the methods used in economic evaluations (EEs) included in health technology assessments (HTAs) of genetic testing technologies (GTTs)...
  2. doi request reprint Patient outcomes after anti TNF-alpha drugs for Crohn's disease
    Nazila Assasi
    Programs for Assessment of Technology in Health Research Institute, St Joseph s Healthcare, Hamilton, 25 Main Street West, Suite 2000 ON, Canada
    Expert Rev Pharmacoecon Outcomes Res 10:163-75. 2010
    ..The review further considers the evidence for the harms and benefits associated with switching from one anti-TNF-alpha agent to another and strategies to optimize the timing of therapy...
  3. ncbi request reprint Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura
    Gord Blackhouse
    Programs for Assessment of Technology in Health PATH Research Institute, McMaster University, Hamilton, Ontario, Canada
    J Popul Ther Clin Pharmacol 19:e166-78. 2012
    ..Treatment options for acute childhood ITP include splenectomy, corticosteroids, and blood products such as intravenous immunoglobulin...
  4. doi request reprint Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease
    Gord Blackhouse
    Programs for Assessment of Technology in Health Research Institute, McMaster University, Hamilton, ON, Canada
    J Crohns Colitis 6:77-85. 2012
    ..However, these medications are quite expensive. The objective of this study is to evaluate the cost-utility of two anti-TNF-α drugs (infliximab, adalimumab) for refractory CD...
  5. doi request reprint Comparative effectiveness of catheter ablation strategies for rhythm control in patients with atrial fibrillation: a meta-analysis
    Nazila Assasi
    Programs for Assessment of Technology in Health Research Institute, McMaster University, Hamilton, ON, Canada L8P 1H1
    J Interv Card Electrophysiol 35:259-75. 2012
    ..Ablation of additional sites has been used to increase the efficacy of ablation procedures in restoring and maintaining normal sinus rhythm...
  6. pmc Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada
    Gord Blackhouse
    PATH Research Institute, McMaster University, Hamilton, Ontario, Canada
    Cost Eff Resour Alloc 8:14. 2010
    ..The objective of the paper is to evaluate, from a Canadian perspective, the cost-effectiveness of IVIG compared to corticosteroid treatment of CIDP...
  7. doi request reprint Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura
    Feng Xie
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    Clin Ther 31:1082-91; discussion 1066-8. 2009
    ..The aim of this work was to estimate the cost-effectiveness of intravenous immunoglobulin (IVIg) compared with oral prednisone as a treatment for Canadian adults with persistent chronic immune thrombocytopenic purpura (ITP)...
  8. doi request reprint Triple therapy for the management of COPD: a review
    Kathryn Gaebel
    Programs for Assessment of Technology in Health PATH Research Institute, McMaster University, Hamilton, Ontario L8P 1H1
    COPD 8:206-43. 2011
    ..There is insufficient evidence to determine if triple therapy is superior to dual bronchodilator therapy...
  9. pmc Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
    Feng Xie
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    Cost Eff Resour Alloc 7:20. 2009
    ..Future research could be aimed at the long-term clinical benefits of these drugs, especially adalimumab for patients intolerant or unresponsive to infliximab treatment...
  10. doi request reprint Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic review
    Nazila Assasi
    Programs for Assessment of Technology in Health PATH Research Institute, McMaster University, Hamilton, ON, Canada
    Expert Rev Pharmacoecon Outcomes Res 14:203-20. 2014
    ..The choice of a method for collection and analysis of ethical data seems to depend on the context in which technology is being assessed, the purpose of analysis, and availability of required resources. ..